146 related articles for article (PubMed ID: 34792202)
1. Metabolomics study reveals systematic metabolic dysregulation and early detection markers associated with incident pancreatic cancer.
Wang S; Li M; Yan L; He M; Lin H; Xu Y; Wan Q; Qin G; Chen G; Xu M; Wang G; Qin Y; Luo Z; Tang X; Wang T; Zhao Z; Xu Y; Chen Y; Huo Y; Hu R; Ye Z; Dai M; Shi L; Gao Z; Su Q; Mu Y; Zhao J; Chen L; Zeng T; Yu X; Li Q; Shen F; Chen L; Zhang Y; Wang Y; Deng H; Liu C; Wu S; Yang T; Li D; Ning G; Wu T; Wang W; Bi Y; Lu J;
Int J Cancer; 2022 Apr; 150(7):1091-1100. PubMed ID: 34792202
[TBL] [Abstract][Full Text] [Related]
2. Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
Che J; Zhao Y; Gu B; Li S; Li Y; Pan K; Sun T; Han X; Lv J; Zhang S; Fan B; Li C; Wang C; Wang J; Zhang T
BMC Cancer; 2023 Dec; 23(1):1238. PubMed ID: 38102546
[TBL] [Abstract][Full Text] [Related]
3. Prospective metabolomics study identifies potential novel blood metabolites associated with pancreatic cancer risk.
Shu X; Zheng W; Yu D; Li HL; Lan Q; Yang G; Cai H; Ma X; Rothman N; Gao YT; Jia W; Xiang YB; Shu XO
Int J Cancer; 2018 Nov; 143(9):2161-2167. PubMed ID: 29717485
[TBL] [Abstract][Full Text] [Related]
4. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
5. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
[TBL] [Abstract][Full Text] [Related]
6. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women.
Jiao L; Maity S; Coarfa C; Rajapakshe K; Chen L; Jin F; Putluri V; Tinker LF; Mo Q; Chen F; Sen S; Sangi-Hyghpeykar H; El-Serag HB; Putluri N
Cancer Prev Res (Phila); 2019 Apr; 12(4):237-246. PubMed ID: 30723176
[TBL] [Abstract][Full Text] [Related]
7. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.
Di Gangi IM; Mazza T; Fontana A; Copetti M; Fusilli C; Ippolito A; Mattivi F; Latiano A; Andriulli A; Vrhovsek U; Pazienza V
Oncotarget; 2016 Feb; 7(5):5815-29. PubMed ID: 26735340
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort.
Han Y; Jung KJ; Kim U; Jeon CI; Lee K; Jee SH
J Transl Med; 2023 Dec; 21(1):878. PubMed ID: 38049855
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
[TBL] [Abstract][Full Text] [Related]
12. Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination.
Itoi T; Sugimoto M; Umeda J; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Moriyasu F; Kasuya K; Nagakawa Y; Abe Y; Takano K; Kawachi S; Shimazu M; Soga T; Tomita M; Sunamura M
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28375170
[TBL] [Abstract][Full Text] [Related]
13. Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
Stolzenberg-Solomon R; Derkach A; Moore S; Weinstein SJ; Albanes D; Sampson J
Gut; 2020 Nov; 69(11):2008-2015. PubMed ID: 32060129
[TBL] [Abstract][Full Text] [Related]
14. Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.
Zhang G; He P; Tan H; Budhu A; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Maitra A; Hanna N; Alexander HR; Hussain SP
Clin Cancer Res; 2013 Sep; 19(18):4983-93. PubMed ID: 23918603
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
Luo X; Liu J; Wang H; Lu H
Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
[TBL] [Abstract][Full Text] [Related]
16. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
17. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma.
Moore HB; Culp-Hill R; Reisz JA; Lawson PJ; Sauaia A; Schulick RD; Del Chiaro M; Nydam TL; Moore EE; Hansen KC; D'Alessandro A
Am J Surg; 2019 Dec; 218(6):1206-1212. PubMed ID: 31514959
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares.
Wang M; Li R; Qi H; Pang L; Cui L; Liu Z; Lu J; Wang R; Hu S; Liang N; Tao Y; Dalbeth N; Merriman TR; Terkeltaub R; Yin H; Li C
Arthritis Rheumatol; 2023 Dec; 75(12):2252-2264. PubMed ID: 37390372
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]